stockrow
Saturday 7 November 2026
Export DHC’s income statement to Excel — free account
Diversified Healthcare Trust
DHC Real Estate Reit Healthcare Facilities
Diversified Healthcare Trust’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 2.84% from fiscal 2024.
- Revenue
- −5.41%
- EPS
- +69.4%
- Free cash flow
- +100.7%
- Total debt
- −11.7%
Quarter to September 2026, against a year earlier
7.02
0.01
−0.14%
Follow DHC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.76 | 1.05 | 1.49 | 1.28 | |
P/FCF ratio |
2.76 | 3.64 | 20.88 | 10.38 | |
P/Operating CF |
(57.95) | 191.58 | 58.33 | 69.06 | |
P/B ratio |
0.70 | 0.99 | 1.41 | 1.24 | |
Price to Tangible BV |
0.70 | 0.99 | 1.41 | 1.24 | |
EV/Sales |
2.53 | 2.84 | 3.30 | 3.12 | |
EV/EBITDA |
28.85 | 29.85 | 30.79 | 19.62 | |
EV/Operating CF |
(198.51) | (536.52) | (218.59) | 85.45 | |
EV/FCF |
9.21 | 9.82 | 46.21 | 25.31 | |
Quick Ratio |
4.10 | 5.36 | 4.67 | 5.32 | |
Current Ratio |
3.97 | 5.36 | 4.67 | 5.32 | |
Net Debt/EBITDA |
38.13 | 37.36 | 35.22 | 44.93 | |
Debt/Assets |
55.05% | 56.28% | 56.69% | 57.38% | |
Debt/Equity |
1.44 | 1.48 | 1.52 | 1.57 | |
Asset Turnover |
0.32 | 0.33 | 0.33 | 0.33 | |
Operating CF/Net income |
0.95 | (0.19) | (1.03) | (0.55) | |
Capex/Depreciation |
2.81 | (0.54) | (0.26) | (0.41) | |
Interest Coverage |
(0.30) | (0.13) | (0.01) | (0.39) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.30% | 3.83% | 5.29% | 3.98% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(2.21) | (1.57) | (1.13) | (1.34) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(24.54%) | (20.03%) | (11.94%) | (8.13%) | |
Free Cash Flow Yield |
36.28% | 27.46% | 4.79% | 9.64% | |
Revenue per Share |
1.58 | 1.52 | 1.52 | 1.53 | |
Operating CF per Share |
(0.08) | 0.03 | 0.16 | 0.11 | |
Capex per Share |
0.86 | (0.15) | (0.07) | (0.11) | |
Free Cash Flow per Share |
0.78 | (0.11) | 0.09 | 0.00 | |
Cash per Share |
0.51 | 0.58 | 0.57 | 0.54 | |
Shareholders Equity per Share |
6.93 | 6.73 | 6.57 | 6.35 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.93 | 6.73 | 6.57 | 6.35 | |
Free Cash Flow |
187.31 | (26.82) | 21.33 | 0.52 | |
Working Capital |
91.12 | 113.77 | 107.00 | 106.32 | |
Capital Expenditures |
207.42 | (35.17) | (17.06) | (26.87) | |
Net Current Asset Value |
(2,573.88) | (2,507.28) | (2,519.67) | (2,528.58) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(0.55) | 0.10 | 0.05 | 0.07 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
2.98 | — | — | — | |
Average Payables |
15.48 | — | — | — | |
Average Assets |
4,749.13 | 4,631.70 | 4,497.57 | 4,436.69 | |
Average Common Equity |
1,812.21 | 1,784.24 | 1,718.90 | 1,609.31 |
Columns are period end dates · fundamentals updated 5 Nov 2026